List of Tables
Table 1. Global Immuno-oncology Diagnosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PCR
Table 3. Key Players of NGS
Table 4. Key Players of Immunoassay
Table 5. Global Immuno-oncology Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Immuno-oncology Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Immuno-oncology Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Immuno-oncology Diagnosis Market Share by Region (2020-2025)
Table 9. Global Immuno-oncology Diagnosis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Immuno-oncology Diagnosis Market Share by Region (2026-2031)
Table 11. Immuno-oncology Diagnosis Market Trends
Table 12. Immuno-oncology Diagnosis Market Drivers
Table 13. Immuno-oncology Diagnosis Market Challenges
Table 14. Immuno-oncology Diagnosis Market Restraints
Table 15. Global Immuno-oncology Diagnosis Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Immuno-oncology Diagnosis Market Share by Players (2020-2025)
Table 17. Global Top Immuno-oncology Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Diagnosis as of 2024)
Table 18. Ranking of Global Top Immuno-oncology Diagnosis Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Immuno-oncology Diagnosis Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Immuno-oncology Diagnosis, Headquarters and Area Served
Table 21. Global Key Players of Immuno-oncology Diagnosis, Product and Application
Table 22. Global Key Players of Immuno-oncology Diagnosis, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immuno-oncology Diagnosis Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Immuno-oncology Diagnosis Revenue Market Share by Type (2020-2025)
Table 26. Global Immuno-oncology Diagnosis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Immuno-oncology Diagnosis Revenue Market Share by Type (2026-2031)
Table 28. Global Immuno-oncology Diagnosis Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Immuno-oncology Diagnosis Revenue Market Share by Application (2020-2025)
Table 30. Global Immuno-oncology Diagnosis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Immuno-oncology Diagnosis Revenue Market Share by Application (2026-2031)
Table 32. North America Immuno-oncology Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Immuno-oncology Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Immuno-oncology Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Immuno-oncology Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Immuno-oncology Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Immuno-oncology Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Immuno-oncology Diagnosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Immuno-oncology Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Immuno-oncology Diagnosis Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Immuno-oncology Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Immuno-oncology Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Immuno-oncology Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Immuno-oncology Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Immuno-oncology Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Immuno-oncology Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 47. 10x Genomics Company Details
Table 48. 10x Genomics Business Overview
Table 49. 10x Genomics Immuno-oncology Diagnosis Product
Table 50. 10x Genomics Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 51. 10x Genomics Recent Development
Table 52. Abbott Laboratories Company Details
Table 53. Abbott Laboratories Business Overview
Table 54. Abbott Laboratories Immuno-oncology Diagnosis Product
Table 55. Abbott Laboratories Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 56. Abbott Laboratories Recent Development
Table 57. Abcam Company Details
Table 58. Abcam Business Overview
Table 59. Abcam Immuno-oncology Diagnosis Product
Table 60. Abcam Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 61. Abcam Recent Development
Table 62. Adaptive Biotechnologies Company Details
Table 63. Adaptive Biotechnologies Business Overview
Table 64. Adaptive Biotechnologies Immuno-oncology Diagnosis Product
Table 65. Adaptive Biotechnologies Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 66. Adaptive Biotechnologies Recent Development
Table 67. Aethlon Medical Company Details
Table 68. Aethlon Medical Business Overview
Table 69. Aethlon Medical Immuno-oncology Diagnosis Product
Table 70. Aethlon Medical Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 71. Aethlon Medical Recent Development
Table 72. Agena Bioscience Company Details
Table 73. Agena Bioscience Business Overview
Table 74. Agena Bioscience Immuno-oncology Diagnosis Product
Table 75. Agena Bioscience Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 76. Agena Bioscience Recent Development
Table 77. Angle plc Company Details
Table 78. Angle plc Business Overview
Table 79. Angle plc Immuno-oncology Diagnosis Product
Table 80. Angle plc Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 81. Angle plc Recent Development
Table 82. Apocell Company Details
Table 83. Apocell Business Overview
Table 84. Apocell Immuno-oncology Diagnosis Product
Table 85. Apocell Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 86. Apocell Recent Development
Table 87. ARUP Laboratories Company Details
Table 88. ARUP Laboratories Business Overview
Table 89. ARUP Laboratories Immuno-oncology Diagnosis Product
Table 90. ARUP Laboratories Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 91. ARUP Laboratories Recent Development
Table 92. Beckman Coulter Company Details
Table 93. Beckman Coulter Business Overview
Table 94. Beckman Coulter Immuno-oncology Diagnosis Product
Table 95. Beckman Coulter Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 96. Beckman Coulter Recent Development
Table 97. Becton Dickinson Company Details
Table 98. Becton Dickinson Business Overview
Table 99. Becton Dickinson Immuno-oncology Diagnosis Product
Table 100. Becton Dickinson Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 101. Becton Dickinson Recent Development
Table 102. Bioarray Genetics Company Details
Table 103. Bioarray Genetics Business Overview
Table 104. Bioarray Genetics Immuno-oncology Diagnosis Product
Table 105. Bioarray Genetics Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 106. Bioarray Genetics Recent Development
Table 107. BioCartis Company Details
Table 108. BioCartis Business Overview
Table 109. BioCartis Immuno-oncology Diagnosis Product
Table 110. BioCartis Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 111. BioCartis Recent Development
Table 112. Biocept Company Details
Table 113. Biocept Business Overview
Table 114. Biocept Immuno-oncology Diagnosis Product
Table 115. Biocept Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 116. Biocept Recent Development
Table 117. Biodesix Inc Company Details
Table 118. Biodesix Inc Business Overview
Table 119. Biodesix Inc Immuno-oncology Diagnosis Product
Table 120. Biodesix Inc Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 121. Biodesix Inc Recent Development
Table 122. BioFluidica Company Details
Table 123. BioFluidica Business Overview
Table 124. BioFluidica Immuno-oncology Diagnosis Product
Table 125. BioFluidica Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 126. BioFluidica Recent Development
Table 127. BioGenex 40 bioMérieux Company Details
Table 128. BioGenex 40 bioMérieux Business Overview
Table 129. BioGenex 40 bioMérieux Immuno-oncology Diagnosis Product
Table 130. BioGenex 40 bioMérieux Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 131. BioGenex 40 bioMérieux Recent Development
Table 132. Bio-Rad Company Details
Table 133. Bio-Rad Business Overview
Table 134. Bio-Rad Immuno-oncology Diagnosis Product
Table 135. Bio-Rad Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 136. Bio-Rad Recent Development
Table 137. Bio-Techne Company Details
Table 138. Bio-Techne Business Overview
Table 139. Bio-Techne Immuno-oncology Diagnosis Product
Table 140. Bio-Techne Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 141. Bio-Techne Recent Development
Table 142. Bristol-Myers Squibb Company Details
Table 143. Bristol-Myers Squibb Business Overview
Table 144. Bristol-Myers Squibb Immuno-oncology Diagnosis Product
Table 145. Bristol-Myers Squibb Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 146. Bristol-Myers Squibb Recent Development
Table 147. Cancer Genetics Company Details
Table 148. Cancer Genetics Business Overview
Table 149. Cancer Genetics Immuno-oncology Diagnosis Product
Table 150. Cancer Genetics Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 151. Cancer Genetics Recent Development
Table 152. Caris Molecular Diagnostics Company Details
Table 153. Caris Molecular Diagnostics Business Overview
Table 154. Caris Molecular Diagnostics Immuno-oncology Diagnosis Product
Table 155. Caris Molecular Diagnostics Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 156. Caris Molecular Diagnostics Recent Development
Table 157. CellMax Life Company Details
Table 158. CellMax Life Business Overview
Table 159. CellMax Life Immuno-oncology Diagnosis Product
Table 160. CellMax Life Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 161. CellMax Life Recent Development
Table 162. Charles River Laboratories Company Details
Table 163. Charles River Laboratories Business Overview
Table 164. Charles River Laboratories Immuno-oncology Diagnosis Product
Table 165. Charles River Laboratories Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 166. Charles River Laboratories Recent Development
Table 167. Chronix Biomedical Company Details
Table 168. Chronix Biomedical Business Overview
Table 169. Chronix Biomedical Immuno-oncology Diagnosis Product
Table 170. Chronix Biomedical Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 171. Chronix Biomedical Recent Development
Table 172. Circulogene Company Details
Table 173. Circulogene Business Overview
Table 174. Circulogene Immuno-oncology Diagnosis Product
Table 175. Circulogene Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 176. Circulogene Recent Development
Table 177. Clearbridge BioMedics Company Details
Table 178. Clearbridge BioMedics Business Overview
Table 179. Clearbridge BioMedics Immuno-oncology Diagnosis Product
Table 180. Clearbridge BioMedics Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 181. Clearbridge BioMedics Recent Development
Table 182. Clinical Genomics Company Details
Table 183. Clinical Genomics Business Overview
Table 184. Clinical Genomics Immuno-oncology Diagnosis Product
Table 185. Clinical Genomics Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 186. Clinical Genomics Recent Development
Table 187. Pfizer Company Details
Table 188. Pfizer Business Overview
Table 189. Pfizer Immuno-oncology Diagnosis Product
Table 190. Pfizer Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 191. Pfizer Recent Development
Table 192. Promega Company Details
Table 193. Promega Business Overview
Table 194. Promega Immuno-oncology Diagnosis Product
Table 195. Promega Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 196. Promega Recent Development
Table 197. Protagen Diagnostics Company Details
Table 198. Protagen Diagnostics Business Overview
Table 199. Protagen Diagnostics Immuno-oncology Diagnosis Product
Table 200. Protagen Diagnostics Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 201. Protagen Diagnostics Recent Development
Table 202. Qiagen Company Details
Table 203. Qiagen Business Overview
Table 204. Qiagen Immuno-oncology Diagnosis Product
Table 205. Qiagen Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 206. Qiagen Recent Development
Table 207. Quanterix Company Details
Table 208. Quanterix Business Overview
Table 209. Quanterix Immuno-oncology Diagnosis Product
Table 210. Quanterix Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 211. Quanterix Recent Development
Table 212. Rarecells SAS Company Details
Table 213. Rarecells SAS Business Overview
Table 214. Rarecells SAS Immuno-oncology Diagnosis Product
Table 215. Rarecells SAS Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 216. Rarecells SAS Recent Development
Table 217. Roche Diagnostics Company Details
Table 218. Roche Diagnostics Business Overview
Table 219. Roche Diagnostics Immuno-oncology Diagnosis Product
Table 220. Roche Diagnostics Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 221. Roche Diagnostics Recent Development
Table 222. Siemens Company Details
Table 223. Siemens Business Overview
Table 224. Siemens Immuno-oncology Diagnosis Product
Table 225. Siemens Revenue in Immuno-oncology Diagnosis Business (2020-2025) & (US$ Million)
Table 226. Siemens Recent Development
Table 227. Research Programs/Design for This Report
Table 228. Key Data Information from Secondary Sources
Table 229. Key Data Information from Primary Sources
Table 230. Authors List of This Report
List of Figures
Figure 1. Immuno-oncology Diagnosis Picture
Figure 2. Global Immuno-oncology Diagnosis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Immuno-oncology Diagnosis Market Share by Type: 2024 VS 2031
Figure 4. PCR Features
Figure 5. NGS Features
Figure 6. Immunoassay Features
Figure 7. Global Immuno-oncology Diagnosis Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Immuno-oncology Diagnosis Market Share by Application: 2024 VS 2031
Figure 9. Research Case Studies
Figure 10. Diagnostics Case Studies
Figure 11. Immuno-oncology Diagnosis Report Years Considered
Figure 12. Global Immuno-oncology Diagnosis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Immuno-oncology Diagnosis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Immuno-oncology Diagnosis Market Share by Region: 2024 VS 2031
Figure 15. Global Immuno-oncology Diagnosis Market Share by Players in 2024
Figure 16. Global Top Immuno-oncology Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Diagnosis as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Immuno-oncology Diagnosis Revenue in 2024
Figure 18. North America Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Immuno-oncology Diagnosis Market Share by Country (2020-2031)
Figure 20. United States Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Immuno-oncology Diagnosis Market Share by Country (2020-2031)
Figure 24. Germany Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Immuno-oncology Diagnosis Market Share by Region (2020-2031)
Figure 32. China Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Immuno-oncology Diagnosis Market Share by Country (2020-2031)
Figure 40. Mexico Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Immuno-oncology Diagnosis Market Share by Country (2020-2031)
Figure 44. Turkey Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Immuno-oncology Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. 10x Genomics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 48. Abbott Laboratories Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 49. Abcam Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 50. Adaptive Biotechnologies Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 51. Aethlon Medical Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 52. Agena Bioscience Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 53. Angle plc Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 54. Apocell Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 55. ARUP Laboratories Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 56. Beckman Coulter Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 57. Becton Dickinson Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 58. Bioarray Genetics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 59. BioCartis Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 60. Biocept Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 61. Biodesix Inc Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 62. BioFluidica Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 63. BioGenex 40 bioMérieux Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 64. Bio-Rad Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 65. Bio-Techne Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 67. Cancer Genetics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 68. Caris Molecular Diagnostics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 69. CellMax Life Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 70. Charles River Laboratories Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 71. Chronix Biomedical Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 72. Circulogene Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 73. Clearbridge BioMedics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 74. Clinical Genomics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 75. Pfizer Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 76. Promega Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 77. Protagen Diagnostics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 78. Qiagen Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 79. Quanterix Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 80. Rarecells SAS Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 81. Roche Diagnostics Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 82. Siemens Revenue Growth Rate in Immuno-oncology Diagnosis Business (2020-2025)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
